Vertex Pharmaceuticals's total assets for Q1 2025 were $22.88B, an increase of 1.54% from the previous quarter. IT:1VRTX total liabilities were $6.38B for the fiscal quarter, a 4.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.